Primary Prevention Aspirin Eligibility Under a Contemporary Risk Framework
JAMA Network Open · 19.11.2026 · 9 (11) · e2646419
DOI: 10.1001/jamanetworkopen.2026.46419 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 19.11.2026. Verfasst von Sridhar Mangalesh und 6 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
This cross-sectional study estimates eligibility for low-dose aspirin for primary prevention based on updated Predicting Risk of Cardiovascular Disease Events risk thresholds.
Zitieren
APA
Mangalesh, S., Kaushik, S., Rossi, R., Nouri, A., Nezhad, S. A., Damluji, A. A., & Nanna, M. G. (2026). Primary Prevention Aspirin Eligibility Under a Contemporary Risk Framework. JAMA Network Open, 9(11), e2646419. https://doi.org/10.1001/jamanetworkopen.2026.46419
Vancouver
Mangalesh S, Kaushik S, Rossi R, Nouri A, Nezhad SA, Damluji AA, et al. Primary Prevention Aspirin Eligibility Under a Contemporary Risk Framework. JAMA Network Open. 2026;9(11):e2646419. doi:10.1001/jamanetworkopen.2026.46419
BibTeX
@article{Mangalesh2026,
author = {Mangalesh, Sridhar and Kaushik, Sharanya and Rossi, Raiza and Nouri, Armin and Nezhad, Shefa Arya and Damluji, Abdulla A. and Nanna, Michael G.},
title = {Primary Prevention Aspirin Eligibility Under a Contemporary Risk Framework},
journal = {JAMA Network Open},
year = {2026},
volume = {9},
number = {11},
pages = {e2646419},
doi = {10.1001/jamanetworkopen.2026.46419}
}
EUVIMED